ALCON INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.3 CHF | +0.72% |
|
+10.24% | +23.61% |
| 05-15 | Stifel Adjusts Price Target on Alcon to $100 From $95, Maintains Buy Rating | MT |
| 05-15 | Oppenheimer Upgrades Alcon to Outperform From Perform, $103 Price Target | MT |
Presentation Operator MessageOperator (Operator)Hello, and welcome to Alcon's Second Quarter 2...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows:
- ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors;
- vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.)
At the end of 2023, the group operated 19 production sites worldwide.
Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
2024-08-20
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.37
USD
Average target price
93.59
USD
Spread / Average Target
+4.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.61% | 44.19B | |
| +13.99% | 102B | |
| +3.48% | 19.46B | |
| -17.14% | 2.32B | |
| +11.49% | 1.87B | |
| +27.62% | 1.23B | |
| -35.12% | 755M | |
| -39.34% | 678M | |
| -7.76% | 674M | |
| +23.43% | 499M |
- Stock Market
- Equities
- ALC Stock
- News Alcon Inc.
- Transcript : Alcon Inc., Q2 2021 Earnings Call, Aug 18, 2021